Arovella Therapeutics Limited (ASX:ALA)

Arovella Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 25, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	106	118	147	42	15	27
Market Cap Growth	-19.46%	-19.46%	246.10%	175.83%	-43.79%	420.70%
Enterprise Value	85	107	142	39	11	22
Last Close Price	0.09	0.10	0.14	0.05	0.02	0.06
PS Ratio	30.77	34.44	75.34	29.21	52.08	27.69
PB Ratio	5.27	5.90	13.10	11.24	2.02	3.05
P/TBV Ratio	5.27	5.90	13.10	11.24	2.06	3.10
EV/Sales Ratio	24.71	31.02	72.90	26.83	37.85	22.28
Debt / Equity Ratio	-	-	-	-	0.02	0.01
Asset Turnover	0.20	0.20	0.21	0.20	0.03	0.11
Quick Ratio	14.06	14.06	6.32	3.08	4.05	4.28
Current Ratio	14.18	14.18	6.45	3.22	4.37	4.33
Return on Equity (ROE)	-47.98%	-47.98%	-116.55%	-178.67%	-103.87%	-76.96%
Return on Assets (ROA)	-28.30%	-28.30%	-59.16%	-73.48%	-47.72%	-28.43%
Return on Capital (ROIC)	-31.54%	-31.54%	-73.93%	-93.48%	-56.45%	-37.23%
Earnings Yield	-7.09%	-6.34%	-5.95%	-23.96%	-55.95%	-18.42%
FCF Yield	-6.94%	-6.20%	-4.79%	-15.06%	-40.91%	-13.54%
Buyback Yield / Dilution	-16.55%	-16.55%	-32.32%	-29.45%	-66.10%	-132.61%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.